Response criteria in oncologic imaging: review of traditional and new criteria.

There has been a proliferation and divergence of imaging-based tumor-specific response criteria over the past 3 decades whose purpose is to achieve objective assessment of treatment response in oncologic clinical trials. The World Health Organization (WHO) criteria, published in 1981, were the first response criteria and made use of bidimensional measurements of tumors. The Response Evaluation Criteria in Solid Tumors (RECIST) were created in 2000 and revised in 2009.

Peritoneal and retroperitoneal anatomy and its relevance for cross-sectional imaging.

It is difficult to identify normal peritoneal folds and ligaments at imaging. However, infectious, inflammatory, neoplastic, and traumatic processes frequently involve the peritoneal cavity and its reflections; thus, it is important to identify the affected peritoneal ligaments and spaces. Knowledge of these structures is important for accurate reporting and helps elucidate the sites of involvement to the surgeon.

Oncocytic neoplasms of the adrenal gland.

Objective: Our study was aimed at review of the radiologic findings on oncocytic neoplasms to identify the features that differentiate these tumors from other adrenal neoplasms.

Conclusion: Benign and malignant oncocytic neoplasms could not be differentiated on the basis of the CT and MRI criteria used for differentiating adrenal cortical adenoma from carcinoma. Oncocytic neoplasms should be considered in the differential diagnosis of indeterminate adrenal tumors.